The Aged Patient with Lung Cancer

作者: Vittorina Zagonel , Umberto Tirelli , Diego Serraino , Giovanni Lo Re , Maria Carmela Merola

DOI: 10.2165/00002512-199404010-00004

关键词:

摘要: Elderly patients with lung cancer have not benefited from the therapeutic improvements obtained during 1980s younger adults. Potentially operable non-small-cell cancers are more common in elderly patients, who likely to localized disease at diagnosis. Even so, rarely treated surgery. Radiotherapy remains most frequently adopted tool treat this age group. Epipodophyllotoxin derivatives constitute best option for chemotherapy of small-cell cancer. When used as single agent regimens, these drugs show same overall response rate combination chemotherapy, but reduced toxicity. Haematopoietic growth factors reduce bone marrow damage following cytotoxic and may be a promising patients. Special attention should given increasing number enrolled phase I II studies investigate new agents treatment tumour.

参考文章(95)
Luther W. Brady, Arnold M. Markoe, Radiation therapy in the elderly patient. Frontiers of Radiation Therapy and Oncology. ,vol. 20, pp. 80- 92 ,(1986) , 10.1159/000411952
Henson D, Feldman Ar, Macfarlane D, Smart Cr, Yancik R, Hunter Cp, Bavier Ar, Dunlap Wh, Ford L, Frelick Rw, Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log. Cancer treatment reports. ,vol. 71, pp. 559- 565 ,(1987)
R Grilli, M Leoni, S Scoccia, C Vergari, U Borghini, G Luporini, E Soresi, M Botturi, M Clerici, R Zucali, A randomized clinical trial comparing radiation therapy v radiation therapy plus cis-dichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Seminars in Oncology. ,vol. 15, pp. 20- 25 ,(1988)
R Feld, W K Evans, P Coy, I Hodson, A S MacDonald, D Osoba, D Payne, W Shelley, J L Pater, Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross-resistant chemotherapy combinations in patients with limited small-cell carcinoma of the lung. Journal of Clinical Oncology. ,vol. 5, pp. 1401- 1409 ,(1987) , 10.1200/JCO.1987.5.9.1401
Alon Yellin, John R. Benfield, Surgery for Bronchogenic Carcinoma in the Elderly1 The American review of respiratory disease. ,vol. 131, pp. 197- ,(1985) , 10.1164/ARRD.1985.131.2.197
K S Albain, J J Crowley, M LeBlanc, R B Livingston, Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. Journal of Clinical Oncology. ,vol. 8, pp. 1563- 1574 ,(1990) , 10.1200/JCO.1990.8.9.1563
U Tirelli, V Zagonel, D Errante, D Serraino, R Talamini, M De Cicco, A Carbone, S Monfardini, A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma. Journal of Clinical Oncology. ,vol. 10, pp. 228- 236 ,(1992) , 10.1200/JCO.1992.10.2.228
G Giaccone, M Donadio, G Bonardi, F Testore, A Calciati, Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy. Journal of Clinical Oncology. ,vol. 6, pp. 1264- 1270 ,(1988) , 10.1200/JCO.1988.6.8.1264
J. Laver, M. A. S. Moore, Clinical Use of Recombinant Human Hematopoietic Growth Factors Journal of the National Cancer Institute. ,vol. 81, pp. 1370- 1382 ,(1989) , 10.1093/JNCI/81.18.1370